Evidence map›Paper›PMID 42100589›Full record

ArticleJCEM case reports2026

Horner syndrome after ethanol ablation for radioactive iodine therapy refractory papillary thyroid carcinoma.

Fidela Anne Badilles, Michael Villa

Abstract readCase Reports
In one paragraph

Article in JCEM case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Fidela Anne BadillesCenter for Diabetes, Thyroid, and Endocrine Disorders, St. Luke's Medical Center, Global City 1634, Philippines.ORCID https://orcid.org/0009-0007-3796-5737
Michael VillaCenter for Diabetes, Thyroid, and Endocrine Disorders, St. Luke's Medical Center, Global City 1634, Philippines.ORCID https://orcid.org/0000-0003-0181-3719

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Papillary thyroid carcinoma (PTC) is the most prevalent form of thyroid malignancy. Although it carries a favorable prognosis, especially for individuals under the age of 45, tumor recurrences in the thyroid bed still occur. In fact, recurrence rates are observed in approximately 20% of patients following initial treatment. For patients who are not candidates for surgery or radioactive iodine therapy, ethanol ablation is a treatment option for recurrences in the thyroid bed and lymph node metastases. This case report details a 31-year-old female patient with a PTC who underwent total thyroidectomy and radioactive iodine therapy. One year later, a locoregional recurrence developed in the thyroid bed. The recurrence was determined to be iodine-refractory, and due to its size and the patient's preference, surgery was not an option; hence ethanol ablation was performed. After the ethanol ablation procedure, the patient exhibited left eyelid drooping. She was diagnosed with Horner syndrome characterized by left upper eyelid ptosis, myosis, and anhidrosis. Although uncommon, Horner syndrome should still be considered as a potential postoperative complication in patients undergoing ethanol ablation for locoregional recurrence of PTC.

Indexed as

ethanol ablationHorner syndromerecurrent papillary thyroid carcinoma

Identifiers

PMID42100589
PMCPMC13148168

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.